![]() |
|
|
|||||||
| Clinical Trials Clinical trials and studies |
![]() |
|
|
Thread Tools | Display Modes |
|
|
#1 |
|
Administrator
Join Date: Jul 2001
Location: New Brunswick, NJ, USA
Posts: 34,571
|
Clinical neuropharmacology of Pain in Spinal Cord Injury
http://www.centerwatch.com/patient/s.../stu28038.html
Summary: Clinical neuropharmacology of Pain in Spinal Cord Injury Massachusetts General Hospital Department of Anesthesia is conducting a research project to evaluate investigational drugs as a treatment for specific types of pain caused by spinal cord injury (SCI). Patient Inclusion/Exclusion Criteria: Individuals between the ages of 18 and 70 with SCI who have had persistent pain for a minimum of 3 months following SCI may be eligible. The study requires 5 or 6 hospital visits over the course of 31 weeks. Contact: Kate Jenkins Research Coordinator Massachusetts General Hospital Fruit Street Boston, MA 02115 Telephone: 617-724-0330 Email: PainTrials@partners.org |
|
|
|
|
|
#2 | |
|
Administrator
Join Date: Jul 2001
Location: New Brunswick, NJ, USA
Posts: 34,571
|
Christine N. Sang, M.D., M.P.H. at the Massachusetts General Hospital is funded by the Christopher Reeve Paralysis Foundation to study the role of glutamate receptor blockers in the treatment of central neuropathic pain in patients after spinal cord injury.
According to the new CRPF description (CRPF Progress in Research, Issue 39, Summer 2001) of the research that is being funded at MGH: Quote:
|
|
|
|
|
|
|
#3 |
|
Administrator
Join Date: Jul 2001
Location: New Brunswick, NJ, USA
Posts: 34,571
|
This trial is also posted on http://www.spinalcord.uab.edu/show.asp?durki=43304
|
|
|
|
![]() |
| Thread Tools | |
| Display Modes | |
|
|